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Abstract
A newly developed procedure for determination of arsenic by radiochemical neutron activation 
analysis (RNAA) was used to measure arsenic at four levels in SRM 955c Toxic Elements in 
Caprine Blood and at two levels in SRM 2668 Toxic Elements in Frozen Human Urine for the 
purpose of providing mass concentration values for certification. Samples were freeze-dried prior 
to analysis followed by neutron irradiation for 3 h at a fluence rate of 1×1014cm−2s−1. After 
sample dissolution in perchloric and nitric acids, arsenic was separated from the matrix by 
extraction into zinc diethyldithiocarbamate in chloroform, and 76As quantified by gamma-ray 
spectroscopy. Differences in chemical yield and counting geometry between samples and 
standards were monitored by measuring the count rate of a 77As tracer added before sample 
dissolution. RNAA results were combined with inductively coupled plasma – mass spectrometry 
(ICP-MS) values from NIST and collaborating laboratories to provide certified values of (10.81 ± 
0.54) μg/kg and (213.1 ± 0.73) μg/kg for SRM 2668 Levels I and II, and certified values of (21.66 
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± 0.73) μg/kg, (52.7 ± 1.1) μg/kg, and (78.8 ± 4.9) μg/kg for SRM 955c Levels 2, 3, and 4 
respectively. Because of discrepancies between values obtained by different methods for SRM 
955c Level 1, an information value of < 5 μg/kg was assigned for this material.
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INTRODUCTION
Exposure of humans to arsenic, even at relatively low levels, has been linked to a variety of 
health problems, including heart disease, skin damage, and lung, bladder, and kidney 
cancers.1–3 As a consequence, arsenic standards for drinking water have been lowered from 
50 μg/L to 10 μg/L in much of the world.4 Monitoring of arsenic levels in drinking water, 
soils, food, and biological tissues is therefore vital to the public health, and this monitoring 
requires reliable methods for determination of arsenic at low levels as well as certified 
reference materials for validation of these methods.
In response to the need for reference materials, the National Institute of Standards and 
Technology has established a continually expanding portfolio of biological Standard 
Reference Materials (SRMs) certified for arsenic content.5 Inductively coupled plasma-
quadrupole mass spectrometry (ICP-qMS), is routinely used at NIST for determination of 
elements at low levels. Determination of arsenic by this method may suffer from 
interference by chlorine at lower μg/kg levels, though to compensate for this, collision cell 
technology (CCT) or high resolution sector field (HR) ICP-MS is used. Certified values 
(values for which NIST has the highest confidence, where all sources of uncertainty or bias 
have been evaluated6) are usually assigned only when two or more independent methods 
(methods with few or no sources of bias in common) have been used to provide 
measurements.
Neutron activation analysis (NAA), which has few sources of uncertainty or bias in common 
with non-nuclear methods of analysis, has played a key role in the certification of arsenic 
and other elements in biological Standard Reference Materials (SRMs). Arsenic is 
quantified by counting of the principal 76As gamma-ray line (559 keV) emitted from 76As, 
t1/2 = 1.09379 d ± 0.00045 d, formed upon neutron capture of 75As. Quantitative 
measurement is based on comparison with As standards prepared from high-purity materials 
irradiated in the same manner. In instrumental neutron activation analysis (INAA), the 
sample is irradiated with neutrons, and then counted after some optimal time period to allow 
decay of shorter-lived radionuclides, thus eliminating uncertainties arising from sample 
dissolution or extraction of arsenic from the matrix. Unfortunately arsenic determination by 
INAA below ≈ 100 μg/kg is often hampered by the presence of significant amounts of 24Na 
(t1/2 = 15 h), 82Br (t1/2 = 35.3 h), or 32P (t1/2 = 14.3 d) resulting in high count rates, high 
dead time, and elevated spectrum baseline due to Compton scattering and Bremsstrahlung 
radiation from 32P. Better As detection limits for NAA may be achieved by using high 
throughput counting or Compton suppression5, but the best detection limits are obtained 
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using radiochemical neutron activation analysis (RNAA), with separation of arsenic from 
the sample matrix prior to counting. Several RNAA procedures for determination of arsenic 
in biological materials were recently evaluated, including absorption of arsenic on hydrated 
manganese dioxide and solvent extraction into chloroform containing zinc 
diethyldithiocarbamate, (ZnDDC2).7 The solvent extraction procedure was found to yield 
the best results, with limits of detection down to ≈ 0.1 μg/kg.
Reflecting the importance of monitoring As and other toxic elements in humans, NIST has 
developed the clinical reference materials, SRM 955c Toxic Elements in Caprine Blood and 
SRM 2668 Toxic Elements in Frozen Human Urine. The concentration of toxic elements in 
blood and urine is routinely measured to track population exposure trends and to monitor 
occupational exposure. ICP-MS had previously been used to provide As reference values for 
SRM 955c, but the values were not certified for lack of data from a second method. 
Reference values represent the best estimate of the true value, but because NIST has not 
fully investigated known or suspected sources of bias, the value does not qualify as a 
certified value. 6 The newly evaluated RNAA solvent extraction procedure was used for the 




SRM 955c Toxic Elements in Caprine Blood was prepared by the New York State 
Department of Health (NYSDOH) according to NIST design and specification. The SRM 
consists of vials of frozen goat blood at four concentration levels. Briefly, Level 1 is 
composed of base blood from undosed adult goats and contains endogenous (trace) levels of 
metals. Levels 2, 3, and 4 are composed of blood pools collected from lead-dosed goats and 
supplemented with As (as As+3), Cd (as Cd+2) and Hg (as Hg+2, MeHg+2, and EtHg+). 
Levels 2, 3, and 4 were spiked to contain approximately 20 μg/L, 50 μg/L, and 80 μg/L of 
arsenic respectively. Homogeneity assessment of the arsenic in Levels 1 and 3 was 
previously performed by ICP-qMS at NIST.
SRM 2668 Toxic Elements in Frozen Human Urine was developed in collaboration with the 
Centers for Disease Control and Prevention (CDC). Each unit of the SRM consists of five 
vials of frozen urine of each of two levels: Level 1, with approximately 10 μg/L of arsenic, 
population geometric mean is similar to the U.S. (≈ 50th -95th percentile distribution) and 
Level 2, with approximately 200 μg/L of arsenic, represents an elevated urine concentration 
(>95th percentile) based on National Report on Human Exposure to Environmental 
Chemicals (2005–2006 National Health and Nutrition Examination Survey). 8
Preparation and irradiation of samples, standards, and controls for RNAA
RNAA measurements were made on all four levels of SRM 955c and on both levels of SRM 
2668. Multiple vials of each material were obtained for analysis. Each vial of blood or urine 
contained between 1.5 mL and 2 mL of liquid, corresponding to a mass of approximately 2 g 
of blood or 1.7 g of urine. For the urine SRM, six vials of each level were sampled, with 
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each vial representing one sample. Twelve samples of Level 1 blood and six samples of 
Level 3 blood were analyzed, each vial again representing one sample. Since no previous 
homogeneity testing was performed on the Level 2 and Level 4 blood, vial contents for these 
materials were divided approximately in half, with each vial used to provide two samples. 
Four vials of each of these two blood levels were sampled, for a total of eight samples of 
each.
All samples were prepared according to the following procedure. A series of linear 
polyethylene (LPE) bags were prepared by heat-sealing polyethylene film. The bags were 
cleaned by soaking in 1 mol/L nitric acid for approximately 24 h, and were then soaked in 
ultra-pure (triply-distilled) water for another 24 h, and finally air-dried in a clean hood for at 
least 48 h. Each bag, with an opening at the top large enough to facilitate easy transfer of the 
liquid, was positioned vertically within a Teflon bottle of approximately the same diameter 
as the bag. A cap was placed on the bottle, and the mass of the bottle and bag recorded. All 
vials of blood and urine were kept frozen until preparation for analysis. Prior to sample 
preparation, vials were removed from the freezer, and the blood or urine was allowed to 
equilibrate to room temperature for several hours. The caps were removed from the Teflon 
bottles and contents from each vial were added to a polyethylene bag, care being taken to 
make sure that no liquid leaked from the bag into the containment bottle. The bottle was 
then capped, and again weighed using an analytical balance. The liquid mass was 
determined by difference, i.e., the mass of sample was equal to the mass of the Teflon bottle 
+ liquid-filled bag minus the mass of the Teflon bottle + empty bag. The capped bottles 
containing the sample-filled bags were transferred to a freezer at −80 °C and kept there 
overnight.
In order to minimize problems encountered in encapsulation and irradiation of liquids (such 
as poorly defined irradiation geometries, sample volatilization, and buildup of pressure 
within the irradiation vessel) the blood and urine samples were freeze-dried prior to analysis. 
This freeze-drying was performed solely to minimize problems associated with irradiation of 
liquids; no quantitative results were obtained from the process. The bottles containing the 
liquid-filled bags were removed from the freezer, the caps removed, and the bottles 
transferred to a freeze dryer at a nominal pressure of 13.3 Pa (0.1 Torr) and a nominal 
temperature of − 40 °C. Samples were freeze-dried for a period of about two weeks, during 
which time the temperature was raised by 5 °C approximately every two days. When a 
nominal temperature of 0 °C was reached, the bottles were removed from the freeze dryer, 
allowed to warm to room temperature, the polyethylene bags removed from the bottles, and 
each bag sealed at the top, with care taken to ensure that none of the contents were lost. 
Each bag and Teflon bottle was inspected for signs of leakage during the freeze-drying 
process; no leaks were detected. Each sample-containing bag was then sealed inside a 
second acid-washed LPE bag, and each doubly encapsulated sample was then sealed into a 
third polyethylene bag made of acid-washed tubular polyethylene to ensure containment 
during irradiation.
For preparation of standards, a solution containing (54.37 ± 0.31) μg/g of arsenic, was 
prepared by gravimetric dilution of SRM 3103a Arsenic Standard Solution. Standards were 
prepared by using a disposable pipet to deposit 2 to 3 drops of the solution onto Whatman 41 
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filter paper. The pipet was weighed before and after dispensing in order to determine the 
mass of solution deposited. Filter papers were allowed to dry for several days in a clean 
hood. Each filter paper containing the dried solution was formed into a disk using a stainless 
steel die and hydraulic press. Filter paper standards were triply encapsulated in polyethylene 
film as described above.
Control materials were prepared by pressing approximately 0.3 g portions of Standard 
Reference Materials, SRM 1575a Pine Needles and SRM 1577c Bovine Liver, into 12.7 mm 
diameter pellets using a stainless steel die and hydraulic press. All control materials were 
triply sealed into polyethylene bags.
Samples, control materials, standards, and iron foil neutron flux monitors (each ≈ 6 mg) 
were packed into polyethylene rabbits (irradiation vessels). Each rabbit typically contained 
two or three blood or urine samples, two standards, one or two controls and two flux 
monitors. Each rabbit was irradiated in the NIST reactor pneumatic tube irradiation facility, 
RT-1, for a total time of 3 h at a reactor power of 20 MW, which provided a thermal neutron 
fluence rate of approximately 1.0 × 1014 cm−2s−1. In order to compensate for a nearly linear 
drop-off of flux as a function of distance along the length of container, i.e., distance from the 
reactor core, each rabbit was flipped, i.e. rotated 180° at the midpoint of the irradiation and 
reinserted. Rabbits were allowed to sit for at least three days prior to sample processing in 
order to allow decay of 24Na in order to minimize radiation exposure to the analyst.
Preparation of 77As tracer solution
Prior to processing of irradiated samples, a solution containing 77As (t1/2 = 1.6179 d)9 was 
prepared for the purpose of estimating corrections arising from differences in arsenic yield 
(fraction of As recovered from the sample) and counting geometry from sample to sample 
and between samples and standards. The preparation of this solution has been described 
previously.7, 10 Approximately 50 mg of high purity (> 99.9 % based on measurement of 
impurities) GeO2 was added to each of two polypropylene snap-top vials. The vials were 
placed in a polyethylene irradiation vessel (rabbit) and irradiated in the NIST reactor 
pneumatic tube irradiation facility, RT-2, for a total time of 6 h at a reactor power of 20 
MW, which provided a thermal neutron fluence rate of approximately 3 × 1013 cm−2s−1. The 
rabbit was flipped at the midpoint of irradiation as described above. Approximately 3 d after 
irradiation, the contents of each polypropylene vial were transferred to a Teflon beaker. 
Each 50 mg GeO2 portion was dissolved by heating in 5 mL of 1 mol/L potassium 
hydroxide solution.* Each dissolved portion was then processed in the following manner to 
separate As from the matrix: 1 mL of 2.5 mol/L H2SO4 was added to neutralize the solution, 
followed by addition of 5 mL H2O, 4.5 mL concentrated H2SO4, and 5 mL 2 mol/L 
potassium iodide solution. The 20 mL total solution was transferred to a 125 mL separatory 
funnel, and As was extracted into 10 mL of toluene. The aqueous phase was discarded and 
the toluene phase washed with two 20 mL portions of 4 mol/L H2SO4/0.5 mol/L KI 
solution. Arsenic was then back-extracted into 10 mL of 10 % (volume fraction) H2SO4. 
*Purity of reagents is not crucial in post-irradiation chemistry: since only radioactive nuclides are being measured, there is little 
possibility of contamination by reagents. Therefore all chemicals used in post-irradiation processing of tracers, samples, standards, and 
controls were reagent grade.
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The 10 mL portions from the GeO2 dissolutions were combined and the 20 mL portion 
heated to boiling on a hot plate while 30 % (volume fraction) H2O2 was added to reduce 
iodide to I2. After no more I2 vapors were observed, the solution was evaporated to 
approximately 2 mL, then allowed to cool, transferred to a polypropylene bottle, and the 
acid residue diluted to approximately 17 mL with singly deionized H2O (referred to as “H2O 
throughout the remainder of the post irradiation chemistry procedure). This solution was 
then set aside as a tracer to be used in the arsenic RNAA procedure. Because the nuclide is 
relatively short-lived, a new solution was prepared for each set of blood or urine irradiations.
Digestion of samples, standards, and controls
Approximately 3 days after irradiation, samples, standards, and controls were removed from 
the rabbits. In order to avoid sample loss and assure complete transfer of each blood or urine 
sample to the dissolution beaker, the following procedure was used. Each sample bag was 
transferred to a Teflon beaker containing 0.1 mL of a solution with approximately 1 mg/g 
As (to serve as carrier) and 1 mL of the 77As tracer solution. Approximately 10 mL of water 
were added to the beaker (sufficient to completely cover the encapsulated sample). A razor 
blade knife was then used to slice open the bags, any residue remaining on the knife was 
rinsed into the beaker with additional water, and 10 mL of concentrated HNO3 were added 
to each beaker. Beakers were covered with Teflon lids and placed on a hot plate with a 
surface temperature of approximately 150 °C to 200 °C for approximately 4 h to 5 h, during 
which time most of the freeze-dried sample was leached off the bags. Lids were removed, 
and each bag was transferred to a second Teflon beaker containing 10 mL of concentrated 
HNO3 and 10 mL H2O, and the beakers covered and heated for an additional 2 hours. Lids 
were again removed, the bag removed from the beaker and rinsed with H2O (rinse added to 
the beaker), and the bag transferred to a counting vial for determination of any 76As 
remaining. The two acid fractions from each sample were combined into one beaker, the 
beaker placed on a hot plate at approximately 200 °C to 250 °C, and the solution evaporated 
to near dryness. Next 10 mL of HNO3 and 10 mL of HClO4 were added to each beaker, and 
the beaker was heated (covered) at 150 °C to 250 °C for approximately 12 h. The lids were 
removed, the surface temperature increased to 250 °C to 280 °C, and the volume of each 
solution reduced to about 1 mL to 2 mL. After beakers were allowed to cool to room 
temperature, an additional 10 mL of HNO3 and 10 mL of HClO4 were added to each beaker 
and the beaker again heated on a hot plate at 150 °C to 250 °C for approximately 12 h. Lids 
were again removed, the hot plate surface temperature increased to 250 °C to 280 °C, and 
the volume of each solution reduced to about 1 mL to 2 mL. Each digest was then set aside 
for further processing.
Standard and control disks were removed from the polyethylene bags and each added to a 
Teflon beaker containing 0.1 mL of the 1 mg/g As solution and 1 mL of the 77As tracer 
solution. Approximately 0.2 g of unirradiated Bovine Liver were added to each beaker 
containing a standard disk in order to minimize errors due to differences in matrix between 
samples and standards. To all beakers containing standards and control materials were added 
10 mL concentrated HNO3 and 10 mL H2O, and each beaker heated (covered) at 150 °C to 
200 °C for 4 to 5 h. Lids were removed, and each beaker was heated at approximately 200 
°C to 250 °C until the solution was evaporated to near dryness. Two additional digestions 
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with 10 mL HClO4 and 10 mL HNO3 were then performed as described in the sample 
procedure above.
Separation of arsenic
Arsenic in the digests was separated by solvent extraction.7, 11 Five milliliters of 
concentrated H2SO4 were added to the digest in each beaker. The beakers were heated 
uncovered at a temperature of 250 °C to 275 °C for about 30 min in order to expel traces of 
HClO4. Each beaker was removed from the hot plate and cooled to room temperature, 
followed by dropwise addition of 15 mL H2O and 1.5 mL of 0.2 mol/L KI solution to reduce 
As5+ to As3+. Beakers were again covered and heated to boiling for 10 to 15 min. Lids were 
removed, 1.5 mL of 0.8 mol/L ascorbic acid added to complete the conversion of As to 
As3+, and the beakers removed from the hot plate and allowed to cool for 30 min.
Each solution was transferred to a 60 mL separatory funnel and extracted with 10 mL of 
0.025 mol/L Zn(DDC)2 in chloroform for about 2 min. The chloroform layer (bottom layer) 
was drained off into a beaker, and the aqueous phase again extracted for 2 min with 5 mL of 
Zn(DDC)2 /chloroform solution. The chloroform phase was drained off, the aqueous phase 
discarded, and the combined 15 mL chloroform phase transferred back to the separatory 
funnel. The chloroform phase was next washed with 5 mL of 2 mol/L H2SO4 containing 100 
mg of ZnSO4 for 2 min, and the chloroform layer drained into a 20 mL plastic liquid 
scintillation counting vial (aqueous phase discarded). Each vial was then set aside for 
determination of 76As and 77As by gamma-ray spectroscopy.
Counting and Data Reduction
Gamma radiations from all processed samples, standards, and controls were collected using 
a high-purity germanium detector with associated electronics, with vials counted at the face 
of the detector. Rinsed polyethylene bags containing blood or urine residue were counted in 
the same geometry. Blood and urine samples and rinsed bags were counted for 
approximately 5 h each; counting times varied for standards and controls. Quantitative 
determination of arsenic was achieved using the 559 keV line from decay of 76As 
(t1/2=1.09379 d ± 0.00045 d).12 Peaks were integrated and fitted using commercial software. 
Sample and control yield/counting geometry corrections were determined relative to 
standards by comparing the 77As count rate for each sample or control with the average 77As 
count rate of the processed standards. Because samples masses and activities were 
determined relative to standards, it was not necessary to know the activity of the tracer or to 
calculate absolute yields. Correction factors determined in this manner generally ranged 
from about 0.9 to 1.1.
Arsenic mass fractions were calculated from 76As count rates measured in samples and 
standards, sample masses, and As mass in standards, corrected by yield/counting geometry 
factors as determined from 77As count rates. Count rates were corrected for pulse pileup 
(where applicable) and radioactive decay. No detectable As was measured in the bag 
residues for the blood; an upper limit for the As content was calculated for each bag (less 
than 2 ng for all bags) and this number was then used to calculate the As uncertainty due to 
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incomplete digestion in the bag. A small amount of arsenic was detected in the bag residues 
for urine, resulting in a correction of approximately 0.5 μg/L applied to the measured values.
Arsenic mass fractions (in μg/kg) for blood and urine were calculated based on the mass of 
the blood and urine measured at room temperature prior to freeze-drying. All values were 
then converted to mass concentrations (in μg/L) using the density of the thawed liquid 
sample at room temperature (liquid temperature at 22 °C). A Mettler/Paar model DMA 35 
density meter was used to measure a density of 1.012 g/mL ± 0.002 g/mL for the SRM 2668 
urine. The calibration of the density meter was verified by measuring the density of 
deionized water at room temperature. The density of the SRM 955c blood was determined 
by a semi-gravimetric method using a Lang-Vey pipet standardized with water. The density 
for each level was determined to 6 decimal points, the average value being approximately 
1.052 g/mL. Individual values for the four levels are listed on the Certificate of Analysis.
Mass fractions for pine needle and bovine liver control materials were calculated on a dry 
mass basis. The dry mass of each sample was calculated by multiplying the measured mass 
(as-received mass) of the sample, by a drying factor determined by drying replicate portions 
of each SRM over magnesium perchlorate to constant weight.
RESULTS AND DISCUSSION
SRM 2668 Toxic Elements in Frozen Human Urine
Table 1 gives mass concentration values for As measured by RNAA in the Level I and Level 
II urine. Standard deviations for both materials do not exceed the combined uncertainties 
from counting statistics, yield determination, and correction for undissolved sample, giving 
no reason to suspect material heterogeneity. Expanded uncertainties (U) were calculated by 
combining uncertainties from individual sources in quadrature to obtain a combined 
standard uncertainty (u), which was then multiplied by a coverage factor of 2 to obtain the 
expanded uncertainty.13 The following sources of uncertainty were evaluated, with 
associated relative uncertainties for the urine and blood measurements in parentheses. (1) 
Uncertainties associated with measurement replication for samples, calculated as 1s/√n (see 
Tables 1, 3, and 4). (2) Uncertainties associated with measurement replication for standards, 
calculated as 1s/√n (0.5 % to 1 %). (3) Uncertainties in the masses of elements in the 
standard, estimated based on uncertainties in metal purity, the mass of each element, the 
mass of solution, and the mass of solution deposited on the filter papers (0.6 %). (4) 
Uncertainties associated with peak integration, estimated based on the evaluation of two 
different peak fitting methods and the assumption of a rectangular distribution of results (5 
% for Level I blood with low count rates and poor counting statistics, 0.1 % to 0.7 % for 
others). (5) Pileup correction uncertainties, estimated from the uncertainty in the pileup 
calibration constant (≤ 0.2 %). (6) Yield/counting geometry correction uncertainty for As, 
estimated from the average counting statistics given by the 239 keV 77As peak and the 
uncertainty in the delivery volume of the 1 mL pipet used to transfer the 77As solution to the 
digestion beakers (≈ 0.5 %). (7) Uncertainties due to incomplete digestion of As in the bag, 
higher uncertainties for lower arsenic levels (0.2 % to 2 %). The uncertainty in the measured 
As residue in the bag was used to determine this uncertainty for urine; the measured upper 
limit for As in the bag was used in the uncertainty determination for the blood. The detection 
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of 76As in urine residue but not blood residue could be due to a number of factors including 
longer count times for the urine residue vs. blood residue resulting in lower As detection 
limits in the urine residue, lower total activity (including lower 82Br) in the urine residue 
resulting in lower As detection limits, or more rigorous acid soaking of the blood filled bags 
resulting in greater removal of the arsenic. 8) All other sources of were deemed insignificant 
(< 0.1 % contribution from each).
Arsenic data used in the certification of the urine were provided by the RNAA and CCT-
ICP-qMS measurements at NIST as well as ICP-MS data from four collaborating 
laboratories.14, 15 Table 2 compares RNAA with other measured values. Values measured 
by RNAA for Level I agree with As mass fractions measured by ICP-MS at NIST and at 
collaborating laboratories. RNAA values for Level II are low compared with NIST CCT-
ICP-qMS values (error bars do not quite overlap – see Table 2), but are in agreement with 
values from collaborating laboratories. No method-based explanation could be found to 
account for the apparent discrepancy between the NIST RNAA and ICP-qMS values. It is 
unlikely that the RNAA measurements for Level II are biased low due to loss during freeze-
drying, irradiation, or dissolution (see discussion of SRM 955c below). It is also unlikely 
that the ICP-MS values are biased high due to polyatomic interferences to 75As such 
as 40Ar35Cl and 40Ca35Cl. At NIST, ICP-qMS measurements of arsenic were performed 
using helium as a collision gas, with kinetic energy discrimination set automatically, which 
should alleviate the effects of polyatomic interferences. The ICP-qMS methods by the 
outside laboratories include similar approaches to eliminate these interferences. 
Furthermore, since the Level I and Level II urine contained approximately same amount of 
chlorine (2.73 mg/L ± 0.12 mg/L and 2.62 mg/L ± 0.10 mg/L), and presumably equal 
amounts of calcium as well since no calcium was added to the Level II urine†, if 40Ar35Cl 
and 40Ca35Cl are contributing to the bias, one would expect the same amount of bias at level 
I. Yet ICP-MS and RNAA agree for Level 1 As. Also, no bias was observed in analysis of 
control materials measured alongside the SRM 2668 samples. The apparent RNAA/ICP-MS 
discrepancy for Level II may be a result of material inhomogeneity. The material 
inhomogeneity, calculated with the statistical Monte Carlo methods in the certification data 
analysis, was incorporated into the expanded uncertainty of the certified values of arsenic; 
yet, this source of uncertainty was unaccounted for in the reported RNAA and the ICP-qMS 
values. If a prediction interval is added to NIST RNAA and CCT-ICP-qMS values to take 
into account the material inhomogeneity, then NAA and ICP-qMS values overlap for the 
Level II arsenic.
Certified mass concentrations are the weighted means of results from NIST and 
collaborating laboratories, found by leveraging a linear, Gaussian random effects statistical 
model and the DerSimonian-Laird procedure. The estimation procedures were supplemented 
by the parametric bootstrap for uncertainty propagation. The certified values for both levels 
are given in Table 2 along with expanded uncertainties.
†No calcium values were measured for SRM 2668, but analysis of calcium in SRM 2670a Toxic Elements in Urine (Freeze-Dried) 
yielded the same amount of calcium in both Low Level and High Level urine.
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SRM 955c Toxic Elements in Caprine Blood
Tables 3 and 4 give mass concentration values for As measured by RNAA at the four 
concentration levels. Table 3 gives values measured for 12 vials of Level 1 blood and 6 vials 
of Level 3 blood. Table 4 gives arsenic values measured for 8 paired samples of each of 
Levels 2 and 4, with each vial of blood providing 2 samples, labeled “a” and “b”. Results 
from individual levels are discussed separately below.
ICP-MS measurements used in the certification campaign were provided by NIST and by a 
number of collaborating laboratories. NIST CCT-ICP-qMS measurements were performed 
on duplicate 1 g portions from eight vials of each of Level 1 and Level 3 blood. In order to 
minimize the interference to 75As from the polyatomic ions 40Ar35Cl and 40Ca35Cl, a 
collision cell was employed using 8 % mole fraction H2 and 92 % He as collision gas. The 
non-NIST measurements were provided as part of a study conducted by the NYSDOH. 
Single, blinded vials of SRM 955c Levels 1 through 4 were distributed for analysis in 
addition to regularly scheduled proficiency testing (PT) samples as part of a special 
laboratories with 8 to 9 laboratories employing ICP-MS and 1 laboratory employing high 
resolution (HR)-ICP-MS.14 Prior to any RNAA measurements being performed, the NIST 
and non-NIST ICP-MS measurements had been used to provide reference values of (2.07 ± 
0.63) μg/L, (21.9 ± 1.7) μg/L, (54.9 ± 3.4) μg/L, and (77.5 ± 4.5) μg/L for arsenic mass 
concentrations of Levels 1, 2, 3, and 4, respectively. Reference values for Levels 2 and 4 
were based solely on data from the non-NIST reference laboratories, while reference values 
for the Level 1 and Level 3 blood were based on NIST CCT-ICP-qMS measurements, with 
corroborating data from the reference laboratories. Values were listed as reference values 
rather than certified values because the methods of analysis used (in all cases ICP-MS) were 
not sufficiently independent to eliminate matrix-induced interference as a source of bias. 
Figure 1 illustrates that mean values obtained by CCT-ICP-qMS from NIST and the non-
NIST reference laboratories for the Level 1 and Level 3 blood agree within the plotted error 
bars (expanded uncertainties), although the error bars for the Level I blood measurements 
for NYSDOH labs represent a relative expanded uncertainty of 76 % due to the As content 
being close to the LOD for most ICP-MS laboratories.
The RNAA value measured here for Level 3 is in agreement with both NIST and non-NIST 
reference laboratory ICP-MS values, and RNAA values for Levels 2 and 4 are in agreement 
with the mean value obtained from the reference laboratories within the expanded 
uncertainties (Figure 1). No heterogeneity was observed in the Level 2 material by RNAA, 
but analyses of the Level 4 blood indicated vial-to-vial heterogeneity. Because of this, 
additional uncertainty was factored into the total uncertainty of the certified value (see 
below).
Arsenic mass concentrations measured by RNAA in Level I blood are low compared with 
ICP-MS values determined at NIST and with the average value obtained from the NYSDOH 
laboratories (Figure 1). With the exception of one outlying value, individual RNAA values 
ranged from about 0.15 μg/L to 0.4 μg/L. Neglecting the outlier, a weighted mean and 
standard deviation of (0.280 ± 0.083) μg/L were calculated for the 11 non-outlying values, 
which is nearly 10 times lower than the mean values reported by ICP-MS. The relative 
standard deviation of 29.4 %, is significantly greater than the combined uncertainties from 
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counting statistics, peak fitting, yield/geometry correction, and losses due to incomplete 
dissolution. This could reflect heterogeneity in the SRM, but there are other possibilities. 
Samples could have been contaminated by transference of 76As contamination from the bags 
to beakers. This would have a significant effect on the results given the very low level of As 
in the blood samples. Even though the bags were thoroughly cleaned, it is possible that 
minute amounts of spot contamination of arsenic were still present in some of the bags, 
which could have been transferred to the beakers along with the blood samples. This 
uncertainty is difficult to assess since each bag may have contained a different amount of 
contamination. Lastly, there is the case of the outlying value of 5.68 μg/L obtained for one 
sample in the second data set. This value is about 20 times the mean of the other eleven 
samples. This could be further evidence of heterogeneity of the SRM, or could reflect a 
contaminated vial or a badly contaminated bag used in sample packaging. Although, nothing 
unusual was noted in the processing of this sample that could account for the high value, it is 
possible that contamination from the bag or through contact with standards may have 
occurred.
Contamination of samples during processing by RNAA cannot explain why the mean value 
obtained by RNAA is nearly 10 times lower than the mean values by ICP-MS. One possible 
explanation for the discrepancy is that RNAA values are biased low due to loss of arsenic 
either during freeze-drying, irradiation, or dissolution prior to equilibration with 77As tracer. 
No apparent arsenic losses were observed for the Levels 2, 3, and 4 bloods, as indicated by 
agreement between RNAA and ICP-MS values. However, those materials were spiked with 
As(III), while arsenic may be dominant in more volatile forms in the natural matrix material. 
Arsenic measured at natural levels in the Level I urine, processed in precisely the same 
manner as the Level I blood, showed no low bias for RNAA, indicating insignificant losses 
compared to the ICP-MS methods. Moreover, the same dissolution method was used in the 
RNAA measurement of arsenic in bovine liver and pine needles controls, and again no low 
bias was observed compared with the certified value (Figure 2). Hence it does not appear 
that a 10-fold low bias in the RNAA measurements is likely to be caused by arsenic loss 
during processing.
Another possible explanation for the discrepancy between RNAA and ICP-MS data is that 
the ICP-MS arsenic values are biased high, possibly due to inadequate correction for an 
isobaric interference. As mentioned earlier, for ICP-MS measurements performed at NIST, 
collision cell technology was used to minimize interferences from 40Ar35Cl and 40Ca35Cl. 
The CCT-ICP-qMS cell conditions are optimized to kinetically discriminate against the 
polyatomic interference. In an attempt to resolve the discrepancy between the RNAA and 
ICP-MS measurements, additional measurements of the Level 1 blood were performed at 
NIST using high resolution (HR) ICP-MS. This method is capable of higher mass resolution 
with capabilities exceeding those of quadrupole ICP-MS. Arsenic concentrations measured 
at NIST in six samples using this method ranged from 0.64 μg/L to 0.91 μg/L with a mean 
value and expanded uncertainty of 0.79 μg/L ± 0.24 μg/L, significantly lower than the mean 
value obtained by CCT-ICP-qMS, but not as low as the RNAA value (Figure 1). The limits 
of detection for measurement of As by RNAA and ICP-MS are relatively comparably in the 
absence of interferences: a detection limit of 0.1 μg/L was calculated for ICP-MS as 3 times 
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the uncertainty in the blank measurements, nearly identical to that determined using the 
RNAA procedure.7
Table 5 summarizes all measurements made on SRM 955c along with previously assigned 
reference values for the four levels and the final arsenic values for the new Certificate of 
Analysis. Table 6 summarizes the statistical evaluation of the certified values. Certified 
values have been assigned for levels 2, 3, and 4. No evidence of material heterogeneity was 
observed for the Levels 2 and 3 bloods. An additional standard uncertainty of 2.342 μg/L 
was added to the Level 4 data to account for vial-to-vial heterogeneity observed in the 
RNAA data. Because of method-to-method discrepancies between results obtained for the 
Level 1 blood, no certified value was assigned for this material. Instead, data from all 
methods were combined to provide an information value of < 5μg/L.
CONCLUSIONS
RNAA has proven an extremely valuable tool for providing measurement used in 
certification of arsenic at low levels in biological reference materials. By providing a 
method independent to ICP-MS, a newly developed RNAA extraction procedure enabled 
assignment of certified values for arsenic mass fractions at three of four levels in SRM 955c 
Toxic Elements in Caprine Blood and at two levels in SRM 2668 Toxic Elements in Frozen 
Human Urine. Because spectrometric interferences are minimized due to separation of 
interfering nuclides prior to counting, the method yields arsenic detection limits down to 0.1 
μg/kg. The method is currently being used to value assign arsenic mass fractions in food 
SRMs at lower μg/kg levels and should continue to prove valuable for arsenic certification 
of future reference materials.
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Arsenic measured in SRM 955c Toxic Elements in Caprine Blood, by ICP-MS and RNAA 
at NIST and by ICP-MS by reference laboratories in collaboration with NYSDOH. Error 
bars represent expanded uncertainties.
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Arsenic measured in controls SRM 1577c Bovine Liver (top) and SRM 1575a Pine Needles 
(bottom) by RNAA, compared with certified values. RNAA values represent the mean of 10 
values, error bars represent expanded uncertainties (U).
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Table 1
RNAA results for determination of As in SRM 2668 Toxic Elements in Frozen Human Urine, Levels I and II 
with evaluation of uncertainties. Uncertainties from counting statistics are given in jarentheses for each 
measurement.
Replicate Sample Number As (μg/L) Level I As (μg/L) Level II
1 10.80 (2.5) 210 (0.3)
2 10.41(2.5) 212 (0.2)
3 10.18 (2.2) 207 (0.3)
4 10.40(1.2) 211 (0.3)
5 10.13 (2.4) 208 (0.3)
6 10.75 (2.0) *
Mean 10.44 209
Standard Deviation 0.28 2
Relative Standard Deviation (%) 2.66 0.94
Relative measurement replication uncertainty (%) 1.1 0.42
Final value (U) 10.44 (0.47) 209 (4.8)
*
A sixth vial of the Level II urine was prepared for analysis, but sample was lost during chemical processing.
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Table 2
Arsenic mass concentration values measured by RNAA and CCT-ICP-qMS at NIST and values contributed by 
outside laboratories along with expanded uncertainties (U). Uncertainties for collaborating labs are based on 
sample replication only, whereas NIST uncertainties represent the true expanded uncertainties. Certified 
values are weighted means of the results.
Level As RNAA (μg/L) As CCT-ICP-qMS NIST (μg/L) As measured by outside laboratories by 
ICP-MS
As certified value (μg/L)
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Table 3
RNAA results for determination of As in SRM 955c Toxic Elements in Caprine Blood, Levels 1 and 3, with 
uncertainties. Uncertainties from counting statistics for each sample are given in parenthesis for Level 1.
Sample designation As (μg/L) Level 1 As (μg/L) Level 3
1 0.393 (10.2%) 52.5
2 0.284 (15.4%) 52.4
3 0.165 (22.5%) 52.0
4 0.380 (12.2%) 53.2
5 0.219 (23.1 %) 52.7
6 0.221 (22.7 %) 54.8
7 0.289 (15.0 %) ---
8 0.277 (16.0 %) ---
9 0.356 (10.6 %) ---
10 0.274 (19.2%) ---
11 5.68 (1.8%)* ---
12 0.146 (40.6%) ---
Mean 0.280 52.9
Standard Deviation 0.083 1.0
Relative Standard Deviation (%) 29.4 1.9
Average relative uncertainty from counting statistics (%) 18.9 0.7
Relative measurement replication uncertainty (%) 8.9 0.79
Final value (U) 0.28 ± 0.06 52.9 (1.5)
*
Anomalous value not included in mean and standard deviation.
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Table 4
RNAA results for determination of As in SRM 955c Toxic Elements in Caprine Blood, Levels 2 and 4, with 
uncertainties, showing paired samples (a and b) from the same vial.










Standard Deviation 0.5 2.2
Relative Standard Deviation (%) 2.15 2.78
Average relative uncertainty from counting statistics (%) 1.3 0.6
Relative measurement replication uncertainty (%) 0.81 % 1.05 %
Final value (U) 21.6 (0.8) 80.1 (2.6)
*
Bag leaked during irradiation; value not included in mean or final value.
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Table 5
Arsenic mass concentrations (in μg/L) measured in SRM 955c. The previous reference value (determined 
using only NIST CCT-ICP-qMS and Reference Lab ICP-MS data) and the new certified value are given. All 
uncertainties are expanded uncertainties (U).












2 no data 21.9 ± 1.7 21.6 ± 0.8 (n=7) no data
21.9 ± 1.7
‡ 21.66 ± 0.73
3 53.9 ± 3.4 51.6 ± 2.4 52.9 ± 1.5 (n=5) no data
53.9 ± 3.4
† 52.7 ± 1.1
4 no data 77.5 ± 4.5 80.1 ± 2.6 (n=7) no data
77.5 ± 4.5
‡ 78.8 ± 4.9
†
Value determined from NIST analyses with corroboration for reference laboratories
‡
Value based on data from reference laboratories
i
Information only value
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Table 6
Statistical evaluation of certified values for SRM 955c, where uc is the combined standard uncertainty, df is 
degrees of freedom, k is the 95 % coverage factor, and U is the expanded uncertainty






df Heterogeneity Uncertainty Suggested Value Type
1 < 5 - - - - none na Information
2 21.66 0.368 183 1.973 0.73 none na Certified
3 52.7 0.53 161 1.975 1.1 none na Certified
4 78.8 2.65 Inf 1.855 4.9 2.342 3 Certified
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